EUVIMEDEUVIMED entdecken
Crossref

Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis

Jianting Qiu, Fangzhou Guo, Ji Shi, Tangjun Guo, Haozhe Piao iD

Journal of Pharmacy and Pharmacology · 2025

DOI: 10.1093/jpp/rgae148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Jianting Qiu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China. Hauptthemen laut MEDLINE: Ferroptosis, Dioxolanes, Glioblastoma, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to investigate the effects of Piperlongumine on Glioblastoma multiforme.

Methods

The effects of Piperlongumine on the viability and proliferation of glioma cells LN229 and A172 were measured. Changes in mitochondrial structure were observed. Cell proliferative capacity was assessed using immunofluorescence. The levels of glutathione, malondialdehyde, 4-hydroxynonenal, and intracellular reactive oxygen species were detected. The levels of ferroptosis-related proteins were detected. A plasmid transfection was performed to overexpress the nuclear factor erythroid 2-related factor 2 gene; a subcutaneous tumor model was established in nude mice to observe the in vivo inhibitory effects of Piperlongumine on Glioblastoma multiforme and the recovery effect of Fer-1. The expression levels of ferroptosis-related proteins were detected using immunohistochemistry. Key findings Piperlongumine inhibited the viability of glioma cells, as well as their proliferation. The ferroptosis inhibitors were able to restore the inhibitory effect of Piperlongumine on glioma cell proliferation. Forced overexpression of nuclear factor erythroid 2-related factor 2 partially reversed Piperlongumine-induced ferroptosis; Piperlongumine exhibited a significant inhibitory effect on Glioblastoma multiforme cells in vivo, which could be restored by Fer-1.

Conclusions

Piperlongumine inhibits Glioblastoma multiforme proliferation by inducing ferroptosis in vitro and vivo model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisDioxolanesGlioblastomaCell ProliferationAntineoplastic Agents, PhytogenicBrain NeoplasmsAnimalsHumansMice, NudeCell Line, TumorMiceReactive Oxygen SpeciesNF-E2-Related Factor 2Cell SurvivalXenograft Model Antitumor AssaysMice, Inbred BALB CPiperidones

Stichwörter der Autor:innen

cystine/glutamate transporterferroptosisglioblastomaglutathione peroxidase 4nuclear factor erythroid 2-related factor 2 genepiperlongumineprostaglandin-endoperoxide synthase 2

Substanzen

piperlongumineDioxolanesReactive Oxygen SpeciesNF-E2-Related Factor 2Antineoplastic Agents, PhytogenicPiperidones

Autor:innen und Institutionen

  • Liaoning University of Traditional Chinese Medicine, Shenyang 110000, China.
  • Department of Neurology, The People's Hospital of Liaoning Province, Shenyang 110000, China.
  • Department of Neurosurgery, Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute, Nanning 530000, China.
  • Department of Neurosurgery, Liaoning Cancer Hospital & Institute, Shenyang 110000, China.
  • Department of Neurosurgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou 221000, China.

ORCID-Profile: Haozhe Piao

Zitieren

APA

Qiu, J., Guo, F., Shi, J., Guo, T., & Piao, H. (2025). Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae148

Vancouver

Qiu J, Guo F, Shi J, Guo T, Piao H. Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgae148

BibTeX
@article{Qiu2025,
  author = {Qiu, Jianting and Guo, Fangzhou and Shi, Ji and Guo, Tangjun and Piao, Haozhe},
  title = {Piperlongumine inhibits glioblastoma proliferation by inducing ferroptosis},
  journal = {Journal of Pharmacy and Pharmacology},
  year = {2025},
  doi = {10.1093/jpp/rgae148}
}
Kostenlos starten →